Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chip Moore

Hand Surgery Abilene, TX Doctor of Osteopathy

NPI 1104314111 CMS profile 7230844

2074 Antilley Rd, Abilene, TX 79606

Open in the dashboard

General payments

$16,331

69 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Chip Moore of Abilene, TX is reported in the CMS Open Payments database as having received $16,331 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $520 21
2024 General $1,739 24
2023 General $407 6
2022 General $1,870 9
2021 General $3,600 3
2019 General $8,195 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chip Moore
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Chip Moore were reported at $520. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Chip Moore Hand Surgery median Middle half National median
2019 $8,195 $383 $106–$1,905 $163
2020 $0 $172 $51–$1,268 $114
2021 $3,600 $263 $71–$1,591 $132
2022 $1,870 $336 $87–$1,938 $149
2023 $407 $233 $81–$1,114 $160
2024 $1,739 $258 $88–$1,203 $164
2025 $520 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pylant Medical $13,574 17 payments
  2. AxoGen $943 15 payments
  3. Stryker Corporation $902 11 payments
  4. Arthrex, Inc. $185 2 payments
  5. Cerapedics, Inc. $168 1 payment
  6. Skeletal Dynamics Inc $92 1 payment
  7. Vertex Pharmaceuticals Incorporated $75 3 payments
  8. Arthrosurface Incorporated $73 2 payments
  9. Amgen Inc. $66 3 payments
  10. AbbVie, Inc. $50 2 payments
  11. Other $204 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $12,952 9 payments
  2. Food and Beverage $2,860 58 payments
  3. Travel and Lodging $520 2 payments
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $943 15 payments
  2. AxoGuard Nerve Connector $943 15 payments
  3. AXOGUARD NERVE PROTECTOR $943 15 payments
  4. Axoguard HA+ Nerve Protector $943 15 payments
  5. AXOGUARD NERVE CAP $943 15 payments
  6. HOFFMANN $284 2 payments
  7. CHARLOTTE $172 1 payment
  8. I-FACTOR PEPTIDE ENHANCED BONE GRAFT $168 1 payment
  9. ASNIS $155 1 payment
  10. VARIAX $127 1 payment
  11. Other $1,041 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

126

Median for Hand Surgery: 118

Drug cost

$777

Median for Hand Surgery: $615

Branded share of claims

30.2%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 29 $263
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $133
Gabapentin Generic 11 $84
Oxycodone Hcl Generic 13 $72
Tramadol Hcl Generic 11 $63
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 15 $61
Cephalexin Generic 13 $60
Ibuprofen Generic 11 $41

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$42,020

Of which drugs: $136

Medicare patients

100

Average age 74

Services billed

1,786

54 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 39%
Ischemic heart disease 35%
Chronic kidney disease 27%
Depression 22%
COPD 18%
Heart failure 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 22 1,280 $125
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 22 120 $11

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record